PharmaCARE's environmental and labor practices in Colberia

Ethics and Corporate Responsibility

The following will be an assessment of firm referred to as PharmaCARE. The assessment will concentrate on the idea of companies that have encountered negative outcomes as a result of company business activities. CERCLA (Comprehensive Environmental Response, Compensation, and Liability Act) will be brought up in this assessment in addition to other environmental safeguarding proposals and human social theories in regards to environmental and work ethics.

A new initiative, We CARE about YOUR world, was recently initiated by PharmaCARE, declaring its dedication to the environment via modifications in packaging, recycling, and other green programs. This was possible in spite of the fact that the firm's lobbying attempts and PAC have effectively conquered environmental policies, such as the broadening of the Superfund tax that was established by Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). Situated in New Jersey, PharmaCARE sustains a huge production facility in the African nation of Colberia. It was in Colberia that the firm discovered various doctors who were excited to freely share data concerning indigenous treatments and plenty of Colberians ready to work for $1.00 per day, harvesting plants through covering five miles into and out of the jungle carrying along with them baskets which weighed up to fifty pounds when full. Owing to the low living standards of Colberia, majority of the population dwell in ancient huts that lack both running water and electric power. However, PharmaCARE managers stay in lavish compounds complete with tennis courts, swimming pools, and golf courses. PharmaCARE's widespread actions in Colberia have led to the destruction of habitats and jeopardy of the native species.

Stakeholder Characteristics

Stakeholders possess certain traits that are influenced by the kind of stakeholder one is or where they work. For instance:

Owners and Shareholders (Karkhanis):

The number of owners and the tasks they perform vary in accordance to the farm size.

There might only be one owner (sole retailer) in the small enterprises or maybe a small number of associates (partnership).

There are frequently huge quantities of shareholders in the huge companies, who each possess a small portion of the enterprise.

Managers (Karkhanis):

Arrange

Come up with decisions

Plan

Manage

Have a responsibility towards the owner(s).

Employees or Staff (Karkhanis):

They consent to work for a certain number of hours in return for a salary.

The levels of payment differ with proficiency, age, location, type of work and others.

Customers (Karkhanis):

The purchase the goods or services produced by the companies.

They might be individuals or other enterprises.

Companies should understand and satisfy the needs of their clients, failing which they will not make profit.

Community (Karkhanis):

Companies and the communities they are located in, are in a two-way kind of relationship.

Majority of the company's clients and employees are usually from the local community.

The enterprise frequently provides goods and services essential to the local region.

However, in certain instances, the community feels upset by various actions conducted by the company.

Government (Karkhanis):

Certain economic guidelines have an effect on the company's cost; via interest rates and taxation.

Legislation controls the operations enterprises can engage in, in regions, like occupational safety and health.

Flourishing companies are suitable for governments since they are sources of employment and wealth.

In this instance, the stakeholders shall be PharmaCARE, the doctors, and the people of Colberia including New Jersey's state government.

Human Rights Issues

The decision made by President Obama in the previous week to reverse U.S. policy and support a U.N. pronouncement on indigenous people's rights has sparked off discussions on if his action could increase the American Indian legal allegations over the mistreatments they have experienced since the colonial era. The president publicized his decision last week at the White House Tribal Nations Conference, leaving the U.S. As the last country to approve the announcement; which had been refuted by the Bush administration from its adoption in 2007 (Berger, 2007).

The non-binding U.N. document entails several stipulations, however, in general, it mentions that the indigenous people should not face discrimination from others, should be allowed to maintain their own social and political systems, in addition to possessing rights to the territories, resources, and lands that they traditionally owned. These ideas are not completely new. As depicted by a wave of current settlements, American Indians possess legal rights to take up discrimination and other allegations against the government. The Obama government argues that it is providing closure to some ancient discrimination and in the process is attempting to strengthen the tribal communities. On the other hand, there exists concern among some concerning the end of the proceedings and the settlements; right on the heights of the Pigford and Cobell cases, a pair of discrimination litigations filed by female and Hispanic laborers is making its way to the courts (Berger, 2010).

Tom Vilsack, the Secretary of Agriculture, has proposed that he intends to close the chapter on them too. Rep. Steve King, R-Iowa, who has been specifically vital to the Pigford allegations procedure, mentions that he is curious concerning the exceptional rights that could be passed on by the U.N. document on indigenous individuals. This particular deed would somehow be in contravention of Colberia's situation. The rights of the individuals who are indigenous to the location are being foregone for the comfort of PharmaCARE. PharmaCARE took away land from the region to build their lavish compounds while the locals of the region stay in huts which would barely pass for adequate shelter (Berger, 2010).

Various modifications can be made by PharmaCARE to alter their ethics for the better. For instance, the communication with patients appeared to be given little priority. Patients were hardly ever informed about the diagnosis, and whatever the patients were told was not passed on to the doctors. A study of 100 letters sent to general practitioners from well recognized surgical units was conducted in 1974. Every patient was diagnosed of confirmed cancer (Calman, 2004).

The general practitioners were informed about the diagnosis in all cases in addition to the description of the surgical process. Once again, my skill as a professor of oncology, in 1974, taught me that it was not common for the patient to be informed about the diagnosis prior to referral. However, things have now changed greatly for the better. Patients are now viewed as complete partners during the procedure and are involved in decision-making. PharmaCARE should hence take the necessary steps to extend to the population of Colberia to see what can be done in connection to what people want and changing the scenario for the better.

Expert values unify groups and offer a means of protecting the public. Expert self-control is hence an outcome of developing primary values, as well as a technique for us understanding modifications in the knowledge basis, novel clinical methods, and modifications in the society values as a whole. Units like the General Medical Council and the state medical councils, are therefore very significant (Calman, 2004).

What is the purpose of values? With regards to being experts, PharmaCARE can make observations to establish what they can alter in the circumstance. Is there anything they can mend with reference to the people? Is there any means by which they can promise to make future key decisions in the most moral manner?

Presently that there exists vivid proof that various lifestyle subjects are strongly related with poor health, with smoking being the clear example, it was just a tiny step to propose that those patients having smoking associated illness should not receive treatment at the National Health Service (NHS) because they had invited the disease themselves. Such a perspective, proposed by various organizations and doctors, would have been put under consideration 20 years ago. Comparable issues could come up with gross obesity, HIV infection and drug abuse (Calman, 2004). To some extent, a similar issue can be viewed regarding the Colberian population.

Environmental Initiative

PharmaCARE's plan in the United States which promises recycling, together with other green proposals is counteracted by their lobbying attempts which were not environmental friendly. In addition, it counters their management of the land and jeopardized life species in Colberia. Hence, their actions seem hypocritical. In 1980, CERCLA was endorsed to fight the fatal health and environmental risks created by industrial pollution. The law requires the president to fund cleanup endeavors from the "Hazardous Substance Superfund" ("Superfund" or the "Fund") upon attainment of specific statutory requirements. Presidential deeds are usually executed via the Environmental Protection Agency (the"EPA"), by a commission of executive authority also approved within the Act (Rotter, 2009).

Outlaws from the fund might be regained via deeds allowed against four classes of likely responsible parties, with the inclusion of any individual who at the period of discarding of any dangerous substance possessed or operated any facility. The Act also offers cleanup liabilities that do not entail expenses from the Fund, like the retrieval of necessary costs of reply sustained by any individual and any damages, loss of natural resources, or obliteration. PharmaCARE, on the other hand, eventually defied this act in addition to circumventing the legal system to keep themselves at abeyance from the act. PharmaCARE, consequently, led to a destruction of the environmental regions.

Comparison

Official investigations into the activities of Enron are currently led by the SEC, the firm's board, congress and the department of justice. The exact details of the disaster may not emerge for months however, the attitudes, motives behind actions and decisions leading to Enron's downfall appear simple enough: personal and corporate greed brought about by the atmosphere of corporate arrogance and market euphoria (Thomas, 2002). The firm made high-risk deals, a number of which were beyond Enron's asset risk control process. Many deals failed in the first half of 2001 and the company's debt rating and stock price imploded because of loss of creditor and investor confidence. The methods the firm used to disclose (or in certain instances obscure) its financial dealings were erroneous and in some instances downright deceptive. It was a clear case of obfuscation. The same charges could be assigned to PharmCare, its methods of expanding the location could be perceived by some as downright unethical. PharmCare's lack of transparency in its financial reporting, followed by its financial restatements showing billions of dollars in omitted losses and liabilities, contributed to its downfall. The whole debacle of Enron unfolded in spite of a team of auditors (who occupied a complete floor), Arthur Andersen LLP, which was tasked with auditing Enron (Thomas, 2002). This is one of the differences between Enron's demise and PharmaCare's downfall. No financial losses were reported by PharmCare when building the new facility. As a matter of fact the company makes huge profits while its employees in the factory, who are indigenous people, are largely deprived of the profits.

On October 22, 2001 Enron reported that the SEC was investigating transactions between the firm and partnerships owned by Fastow, who was fired a few days later. On November 8, Enron released a restatement of the company's financial statements dating back to 1997 to reflect the addition of the SPE's it had omitted, as well as to consolidate Andersen LLP's recommended adjustments from that period, which Enron had previously regarded as immaterial. These restatements resulted in a further $591 and $628 million in losses and additional liabilities respectively by the end of 2000. The equity markets quickly responded to these restatements, driving Enron's stock price to less than ten dollars a share (Thomas, 2002). Another notable difference between PharmCare and Enron, is that at the end of it all, PharmaCARE did not incur or report any financial loss unlike Enron.